FdaApplication
BLA 761219
Identifiers
- fda_app_no: BLA761219
Properties
| Property | Value |
|---|---|
| applicant_name | CELLTRION, Inc. |
| application_type | BLA |
| approval_date | 2023-05-23 |
Products (6)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| YUFLYMA | ADALIMUMAB-AATY | 40MG/0.4ML | Injection |
| YUFLYMA | — | 10MG/0.1ML | Injection |
| YUFLYMA | — | 40MG/0.4ML | Injection |
| YUFLYMA | — | 80MG/0.8ML | Injection |
| YUFLYMA | — | 20MG/0.2ML | Injection |
| YUFLYMA | — | 80MG/0.8ML | Injection |
6 products